Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1997-02-13
1999-07-13
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514261, 514262, 514263, A01N 5700, A01N 4390, A61K 31675, A61K 3152
Patent
active
059226943
ABSTRACT:
A therapeutic method is provided, employing an antiviral compound of the general formula: ##STR1## wherein Z is H, OR' or N(R).sub.2, where n R' is H, (C.sub.1 -C.sub.4)alkyl, aryl, CHO, (C.sub.1 -C.sub.16)alkanoyl or O.dbd.P (OH).sub.2, Y is CH or N, and X is selected from the group consisting of H, N(R).sub.2, SR, OR' or halogen, wherein R is H, lower(C.sub.1 -C.sub.4)alkyl, aryl or mixtures thereof, and the pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 3775397 (1973-11-01), Etzold et al.
patent: 3817982 (1974-06-01), Verhaden et al.
patent: 3917837 (1975-11-01), Lin et al.
patent: 4076711 (1978-02-01), Ganguly et al.
patent: 4115438 (1978-09-01), Woessner et al.
patent: 4138562 (1979-02-01), Vince
patent: 4223156 (1980-09-01), Vince
patent: 4268672 (1981-05-01), Vince
patent: 4362729 (1982-12-01), Vince
patent: 4383114 (1983-05-01), Vince
patent: 4543255 (1985-09-01), Shealy et al.
patent: 4636383 (1987-01-01), Nagabhushan et al.
patent: 4710492 (1987-12-01), Lin et al.
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4742064 (1988-05-01), Vince
patent: 4859677 (1989-08-01), Borchardt et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4916122 (1990-04-01), Chu et al.
patent: 4916224 (1990-04-01), Vince et al.
patent: 4931559 (1990-06-01), Vince et al.
patent: 4950758 (1990-08-01), Vince et al.
patent: 4968674 (1990-11-01), Taniyama et al.
patent: 4999428 (1991-03-01), Saksena et al.
patent: 5034394 (1991-07-01), Daluge
patent: 5087697 (1992-02-01), Daluge
patent: 5122517 (1992-06-01), Vince et al.
patent: 5175292 (1992-12-01), Vince et al.
Broder, et al., "Proc. Natl. Acad. Sci. USA", Proc. Natl. Acad. Sci. USA, 83, 1911 (1986).
Broder(ed), "AIDS: Modern Concepts and Therapeutic Challenges", Marcel Dekker, Inc. N.Y., 318, (1987).
Schmidt, R.R., et al., "1H-1,2,4-Triazol-nucleoside--Snythese von Virazol", Chem. Ber., 114, 2825-2833, (1981).
NIH Grant No. 1 RO1 CA 23263-01 (Feb. 21, 1979).
NIH Grant No. 2 RO1 CA 23263-04 (Apr. 11, 1983).
NIH Grant No. 2 RO1 CA 23263-07 (May 22, 1986).
NIH Grant No. 5 RO1 CA 23263-02 (Dec. 10, 1979).
NIH Grant No. 5 RO1 CA 23263-02 (Jun. 13, 1980).
NIH Grant No. 5 RO1 CA 23263-05 (Dec. 15, 1983).
NIH Grant No. 5 RO1 CA 23263-06 (May 22, 1986).
NIH Grant No. 5 RO1 CA 23263-08 (Jun. 19, 1987).
NIH Grant No. 5 RO1 CA 23263-03 (Dec. 31, 1980).
NIH Grant No. 5 RO1 CA 23263-06 (Dec. 14, 1984).
Balzarini, J., et al., "Anti-Retrovirus Activity of 3'-Fluoro- and 3'-Azido-Substituted Pyrimidine 2',3'-Dideoxynucleoside Analaogues", Biochem. Pharmacol., 37, 2847-2856 (1988).
Baum, R.M., "AIDS Researchers Make Inroads In Understanding a Complex Virus", C&EN, 7-12, (Dec. 1, 1986).
Brouwer, K.R., et al., "The Pharmacokinetics of (-)-Carbovir in Rats: Evidence for Nonlinear Elimination", Drug Metabolism and Disposition, 18, 1078-1083 (1990).
Carter, S.G., et al., "Activities of (-)-Carbovir and 3'-Azido-3'-Deoxythymidine against Human Immunodeficiency Virus in vitro", Antimicrobial Agents and Chemotherapy, 34, 1297-1300 (1990).
Chu, K.C., et al., "Comparative Activity of 2',3'-Saturated and Unsaturated Pyrimidine and Purine Nucleosides against Human Immunodeficiency Virus Type I in Peripheral Blood Mononuclear Cells", Biochem. Pharmacol., 37, 3543-3548 (1988).
Dagani, R., "Efforts Intensify to Develop Drugs, Vaccines that Combat AIDS", C&EN, 7-14 (Dec. 8, 1986).
Dagani, R., "Search for AIDS-Retarding Drugs Yields Potential New Candidates" C&EN, 25-27, (Jun. 29, 1987).
Davoll, J., "A Synthesis of Crotonoside", J. Am. Chem. Soc., 73, 3174-3176 (Jul.-Sep., 1951).
De Clercq, E., "Chemotherapeutic Approaches to the Treatment of the Acquired Immune Deficiency Syndrome (AIDS)", J. Med. Chem., 29, 1561-1569 (1986).
Fischl, M.A., et al., "The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex", New Engl. J. Med., 317, 185-191 (1987).
Hamamoto, Y., et al., "Inhibitory Effect of 2',3'-Didehydro-2',3'-Dideoxynucleosides on Infectivity, Cytopathic Effects, and Replication of Human Immuno Deficiency Virus", Antimicrobial Agents and Chemotherapy, 31, 907-910 (1987).
Hampton, A., et al., "Species- or Isozyme-Specific Enzyme Inhibitors. 5. Differential Effects of Thymidine Substituents on Affinity for Rat Thymidine Kinase Isozymes", J. Med. Chem., 25, 644-649 (1982).
Herdewijn, P., et al., "Synthesis and Anti-HIV Activity of Various 2'- and 3'-Substituted 2',3'-Dideoxyadenosines: A Structure-Activity Analysis", J. Med. Chem., 30, 2131-2137 (1987).
Herdewijn, P., et al., "Synthesis and Anti-HIV Activity of Different Sugar-Modified Pyrimidine and Purine Nucleosides", J. Med. Chem., 31, 2040-2048 (1988).
Ito, Y., et al., "Regioselective Synthesis of Virazole Using Benzyl Cyanofarmate as a Sython", Tetrahedron Letters, 2521-2524 (1979).
Kam, B.L., et al., "Carbocyclic Sugar Amines: Synthesis and Stereochemistry of Racemic .alpha.- and .beta.-Carbocyclic Ribofuranosylamine, Carbocyclic Lyxofuranosylamine, and Related Compounds", J. Org. Chem., 46, 3268-3272 (1981).
Lee, H., et al., "Carbocyclic Analogs of Arabinosylpurine Nucleosides" Chemical Abstracts, 94, 395, No. 4203g (1981).
Lin, T., et al., "Antiviral Activity of 2',3'-Dideoxycytidin-2'-ene (2'-3'-Dideoxsy-2', 3'-Didehydrocytidine) against Human Immunodeficiency Virus in vitro", Biochem. Pharmacol., 36, 311-316 (1987).
Lin, T., et al., "Synthesis and Antiviral Activity of Various 3'-Azido Analogues of Pyrimidine Deoxyribonucleosides against Human Immunodeficiency Virus (HIV-1, HTLV-III/LAV)", J. Med. Chem., 31, 336-340 (1988).
Mitsuya, H., et al., "Long-Term Inhibition of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus (Human Immunodeficiency Virus) DNA Synthesis and RNA Expression in T Cells Protected by 2',3'-Dideoxynucleosides in vitro", Proc. Natl. Acad. Sci. USA., 84, 2033-2037 (Apr. 1987).
Montgomery, J.A., et al., "Isonucleosides. 2. Purine and Pyrimidine Derivatives of 1,4-Anhydro-2-deoxy-D-arabinitol", J. Org. Chem., 43, 541-544 (1978).
Nair, V., et al., "2-Halogenated Purine Nucleosides: Synthesis and Reactivity" J. Org. Chem., 52, 1344-1347 (1987).
Reisinger, E.C., et al., "Inhibition of HIV Progression by Dithiocarb", The Lancet, 335, 679-682 (1990).
Robins, R.K., "Synthetic Antiviral Agents", C&EN, 28-40 (Jan. 27, 1986).
Sandstrom, E.G., et al., "Antiviral Therapy in AIDS: Clinical Pharmacological Properties and Therapeutic Experience to Date", Drugs, 34, 372-390 (1987).
Shealy, Y.F., et al., "Carbocyclic Analogs of Thymine Nucleosides and Related 1-Substituted Thymines", J. Heterocyclic Chem., 18, 383-389 (Mar. 1981).
Shealy, Y.F., et al., "Synthesis and Antiviral Evaluation of Carbocyclic Analogues of 2-Amino-6-Substituted-Purine 3'-Deoxyribofuranosides", J. Med. Chem., 30, 1090-1094 (1987).
Trost, B.M., et al., "A Transition-Metal-Controlled Synthesis of (.+-.)-Aristeromycin and (.+-.)-2',3'-Diepi-Aristeromycin. An Unusual Directive Effect in Hydroxylations", J. Am. Chem. Soc., 110, 621-622 (1988).
Vince, R., et al., "Carbocyclic Arabinosyladenine, and Adenosine Deaminase Resistant Antiviral Agent" Chemical Abstracts, 86, 20, No. 165109f (1977).
Vince, R., et al., "Carbocyclic Arabinofuranosyladenine (Cyclaradine): Efficacy against Genital Herpes in Guinea Pigs" Chemical Abstracts, 99, 33, No. 187143h (1983).
Vince, R., et al., "Carbocyclic Analogues of Xylofuranosylpurine Nucleosides. Sythesis and Antitumor Activity", J. Med. Chem., 27, 1358-1360 (1984).
Vince, R., et al., "Carbocylic Arabinofuranosyladenine (Cyclaradine): Efficacy against Genital Herpes in Guinea Pigs", Science, 221, 1405-1406 (1983).
Vince, R., et al., "Synthesis and Antiviral Activity of Carbocyclic Analogues of Xylofuranosides of 2-Amino-6-substituted-purines and 2-Amino-6-substituted-8-azapurines", J. Med. Chem., 30, 2026-2030 (1987).
Vogt, M.W., et al., "Ribavirin Antagonizes the Effect of Azidothymidine on HIV Replication", Science, 235, 1376-1379 (1987).
Walsh, J.S., et al., "The Metabolism and Excretion of Carbovir, a Carbocyclic Nucleoside, in the Rat", Drug Metabolism and Disposition, 18, 1084-1091 (1990).
Williamson, C., et al., "(
Hua Mei
Vince Robert
Cook Rebecca
Regents of the University of Minnesota
LandOfFree
Optically-active isomers of dideoxycarbocyclic nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically-active isomers of dideoxycarbocyclic nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically-active isomers of dideoxycarbocyclic nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2275826